This article was originally published here<\/p>\n
PLoS One. 2021 Dec 9;16(12):e0259852. doi: 10.1371\/journal.pone.0259852. eCollection 2021.<\/p>\n
ABSTRACT<\/p>\n
This study aimed to investigate the perceived threat, mental health outcomes, behavior changes, and associated predictors among psoriasis patients during the COVID-19 pandemic. The COVID-19 has been known to increase the health risks of patients with psoriasis owing to patients immune dysregulation, comorbidities, and immunosuppressive drug use. A total of 423 psoriasis patients not infected with COVID-19 was recruited from the Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Chang Gung Memorial Hospital, and China Medical University Hospital from May 2020 to July 2020. A self-administered questionnaire was used to evaluate the perceived threat, mental health, and psychological impact on psoriasis patients using the Perceived COVID-19-Related Risk Scale score for Psoriasis (PCRSP), depression, anxiety, insomnia, and stress-associated symptoms (DAISS) scales, and Impact of Event Scale-Revised (IES-R), respectively. Over 94% of 423 patients with psoriasis perceived threat to be 1 due to COVID-19; 18% of the patients experienced psychological symptoms more frequently 1, and 22% perceived psychological impact during the pandemic to be 1. Multivariable linear regression showed that the higher psoriasis severity and comorbidities were significantly associated with higher PCRSP, DAISS, and IES-R scores. The requirement for a prolonged prescription and canceling or deferring clinic visits for psoriasis treatment among patients are the two most common healthcare-seeking behavior changes during the COVID-19 pandemic. Psoriasis patients who perceived a higher COVID-19 threat were more likely to require a prolonged prescription and have their clinic visits canceled or deferred. Surveillance of the psychological consequences in psoriasis patients due to COVID-19 must be implemented to avoid psychological consequences and inappropriate treatment delays or withdrawal.<\/p>\n
PMID:34882690 | DOI:10.1371\/journal.pone.0259852<\/p>\n
<\/p>\n
View original post here:<\/p>\n
Perception of the threat, mental health burden, and healthcare-seeking behavior change among psoriasis patients during the COVID-19 pandemic - DocWire...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" This article was originally published here PLoS One. 2021 Dec 9;16(12):e0259852. doi: 10.1371\/journal.pone.0259852. Continue reading